Verteporfin plus ranibizumab for choroidal neovascularization in age-related macular degeneration: twelve-month MONT BLANC study results
Research output: Contribution to journal › Journal article › Research › peer-review
To compare the efficacy and safety of same-day verteporfin photodynamic therapy (PDT) and intravitreal ranibizumab combination treatment versus ranibizumab monotherapy in neovascular age-related macular degeneration.
Original language | English |
---|---|
Journal | Ophthalmology |
Volume | 119 |
Issue number | 5 |
Pages (from-to) | 992-1000 |
Number of pages | 9 |
ISSN | 0161-6420 |
DOIs | |
Publication status | Published - 2012 |
ID: 48509739